Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study-Reference-Cited by-同舟云学术

Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study

Published:2023-01 Issue:1 Volume:209 Page:131-139
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Lee Hye Won¹,Lee Hyung Ho¹,Park Eun Young²,Park Weon Seo³,Kim Sung Han¹,Joung Jae Young¹,Chung Jinsoo¹,Seo Ho Kyung¹⁴⁵

Affiliation:

1. Department of Urology, Center for Urologic Cancer, National Cancer Center, Goyang, Korea

2. Biostatistics Collaboration Team, Research Core Center, National Cancer Center, Goyang, Korea

3. Department of Pathology, Center for Urologic Cancer, National Cancer Center, Goyang, Korea

4. Division of tumor immunology, Research Institute and Hospital of National Cancer Center, Goyang, Korea

5. Department of Cancer Biomedical Science, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Link

http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000003002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update;European Urology;2024-08

2. Local Drug Delivery in Bladder Cancer: Advances of Nano/Micro/Macro-Scale Drug Delivery Systems;Pharmaceutics;2023-12-03

3. Re: Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients with Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study;European Urology;2023-10

4. First-line Intravesical Chemotherapy for Non–muscle-invasive Bladder Cancer: Chimera or “Ne Plus Ultra”?;European Urology;2023-07

5. Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients With Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study. Letter.;Journal of Urology;2023-05